Cellosaurus MDA-MB-453 Ad15 (CVCL_ZZ23)
| Cell line name | MDA-MB-453 Ad15 |
|---|---|
| Accession | CVCL_ZZ23 |
| Resource Identification Initiative | To cite this cell line use: MDA-MB-453 Ad15 (RRID:CVCL_ZZ23) |
| Comments | Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian. Doubling time: 120.5 hours (PubMed=9815641). Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409. |
| Sequence variations |
|
| Disease | Breast adenocarcinoma (NCIt: C5214) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0418 (MDA-MB-453) |
| Sex of cell | Female |
| Age at sampling | 48Y |
| Category | Cancer cell line |
| Publications | PubMed=9815641 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_ZZ23 |
| Encyclopedic resources | Wikidata; Q102114522 |
| Entry history | |
| Entry creation | 29-Oct-2020 |
| Last entry update | 19-Dec-2024 |
| Version number | 8 |